trending Market Intelligence /marketintelligence/en/news-insights/trending/ar30XaitTtFDknDZS2mPuA2 content esgSubNav
In This List

Canada's Chemesis International acquires cannabidiol product line

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


Canada's Chemesis International acquires cannabidiol product line

Chemesis International Inc. acquired Viverian, a hemp-derived cannabidiol product portfolio.

The Viverian product line includes cannabidiol tinctures and capsules for improved sleep and wellness, and is being distributed in Arizona, Nevada and Florida through an online e-commerce platform.

As part of the deal, Vancouver, British Columbia-based Chemesis will pay US$500,000 in stock priced at market close Dec. 14.

The retail cannabis distributor will expand into a retail strategy and additional states for online shipping in 2019, once cannabidiol regulations are put into place.